Impact of the GH-cortisol ratio on the age-dependent changes in body composition (Q30309693)

16 June 2017

1 reference

title

Impact of the GH-cortisol ratio on the age-dependent changes in body composition (English)

1 reference

16 June 2017

0 references

Nass R

1

1 reference

16 June 2017

Thorner MO

series ordinal

2

1 reference

16 June 2017

publication date

1 June 2002

1 reference

Growth Hormone & I G F Research

16 June 2017

published in

1 reference

16 June 2017

volume

12

1 reference

16 June 2017

issue

3

1 reference

16 June 2017

page(s)

147-161

1 reference

Abdominal visceral fat and fasting insulin are important predictors of 24-hour GH release independent of age, gender, and other physiological factors

16 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Studies in the distribution of body fat: I. Effects of age, sex, and obesity

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Subcutaneous and visceral fat distribution according to sex, age, and overweight, evaluated by computed tomography

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Adult lean body mass declines with age: some longitudinal observations

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Growth hormone, body composition, and aging

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Skeletal aging understanding the functional and structural basis of osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Bone mineral density in elderly men and women: results from the Framingham osteoporosis study

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

The influence of age on the 24-hour integrated concentration of growth hormone in normal individuals

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Effects of human growth hormone in men over 60 years old

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Reduced bone mineral density in patients with adult onset growth hormone deficiency.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Reduced bone mineral content in adult patients with growth hormone deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Increased prevalence of osteoporosis and arteriosclerosis in conventionally substituted anterior pituitary insufficiency: need for additional growth hormone substitution?

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Increased body fat mass and decreased extracellular fluid volume in adults with growth hormone deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Adipose tissue assessed by magnetic resonance imaging in growth hormone-deficient adults: the effect of growth hormone replacement and a comparison with control subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Magnetic resonance imaging-assessed adipose tissue and serum lipid and insulin concentrations in growth hormone-deficient adults. Effect of growth hormone replacement

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Obesity, Fat Patterning and Cardiovascular Risk

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Ultrasonography for the evaluation of visceral fat and cardiovascular risk

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Visceral fat accumulation contributes to insulin resistance, small-sized low-density lipoprotein, and progression of coronary artery disease in middle-aged non-obese Japanese men.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Elevated C-reactive protein: another component of the atherothrombotic profile of abdominal obesity

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Contribution of visceral obesity to the deterioration of the metabolic risk profile in men with impaired glucose tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Fat and protein redistribution with aging: metabolic considerations.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Effects of recombinant insulin-like growth factor-I and growth hormone on bone turnover in elderly women

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Growth hormone replacement in healthy older men improves body composition but not functional ability

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Effects of single nightly injections of growth hormone-releasing hormone (GHRH 1-29) in healthy elderly men

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

With aging in humans the activity of the hypothalamus-pituitary-adrenal system increases and its diurnal amplitude flattens.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Does central obesity reflect "Cushing's disease of the omentum"?

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Growth hormone treatment of adults with growth hormone deficiency: results of a 13-month placebo controlled cross-over study

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

The effect of growth hormone administration in growth hormone deficient adults on bone, protein, carbohydrate and lipid homeostasis, as well as on body composition

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Skeletal muscle performance in adults with growth hormone deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Premature mortality due to cardiovascular disease in hypopituitarism

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Low bone mineral density in adults with previous hypothalamic-pituitary tumors: correlations with serum growth hormone responses to GH-releasing hormone, insulin-like growth factor I, and IGF binding protein 3.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Skin collagen and thickness in acromegaly and hypopituitarism

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Beneficial effects of growth hormone treatment in GH-deficient adults

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Growth hormone treatment in growth hormone-deficient adults. II. Effects on exercise performance

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Short and long-term effects of growth hormone treatment on bone turnover and bone mineral content in adult growth hormone-deficient males

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Effects of physiologic growth hormone therapy on bone density and body composition in patients with adult-onset growth hormone deficiency. A randomized, placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

The influence of gender on the short and long-term effects of growth hormone replacement on bone metabolism and bone mineral density in hypopituitary adults: a 5-year study

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Effect of growth hormone on plasma fatty acids

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Molecular and cellular actions of a structural domain of human growth hormone (AOD9401) on lipid metabolism in Zucker fatty rats.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Growth hormone deficiency in 'little' mice results in aberrant body composition, reduced insulin-like growth factor-I and insulin-like growth factor-binding protein-3 (IGFBP-3), but does not affect IGFBP-2, -1 or -4

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Development of obesity in transgenic rats with low circulating growth hormone levels: involvement of leptin resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Growth patterns and body composition of transgenic mice expressing mutated bovine somatotropin genes

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

The endocrinology of obesity

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Pituitary response to insulin-induced hypoglycemia in obese subjects before and after fasting

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Impaired growth hormone responses to growth hormone-releasing factor in obesity. A pituitary defect reversed with weight reduction

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Impaired growth hormone response to growth hormone releasing factor and insulin-hypoglycaemia in obesity

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Effect of central cholinergic neurotransmission enhancement by pyridostigmine on the growth hormone secretion elicited by clonidine, arginine, or hypoglycemia in normal and obese subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Enhanced growth hormone (GH) responsiveness to GH-releasing hormone after dietary manipulation in obese and nonobese subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Effect of weight reduction, triiodothyronine, and diethylstilbestrol on growth hormone in obesity

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

The effect of hypocaloric diet with and without D-fenfluramine treatment on growth hormone release after growth hormone-releasing factor stimulation in patients with android obesity

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Acute pharmacologic blockade of lipolysis normalizes nocturnal growth hormone levels and pulsatility in obese subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Free fatty acids block growth hormone (GH) releasing hormone-stimulated GH secretion in man directly at the pituitary

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Acipimox potentiates growth hormone (GH) response to GH-releasing hormone with or without pyridostigmine by lowering serum free fatty acid in normal and obese subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Acipimox potentiates growth hormone response to growth hormone-releasing hormone by decreasing serum free fatty acid levels in hyperthyroidism

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Long-term administration of acipimox potentiates growth hormone response to growth hormone-releasing hormone by decreasing serum free fatty acid in obesity

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

The impact of obesity, fat distribution, and energy restriction on insulin-like growth factor-1 (IGF-1), IGF-binding protein-3, insulin, and growth hormone

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Postmenopausal hormone replacement therapy prevents central distribution of body fat after menopause

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Obesity: new insight into the anthropometric classification of fat distribution shown by computed tomography

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Contribution of abdominal adiposity to age-related differences in insulin sensitivity and plasma lipids in healthy nonobese women

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Age changes in body composition revealed by computed tomography

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Body fat distribution in healthy young and older men

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Consequences of childhood-onset growth hormone deficiency for adult bone mass

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Low serum IGF-1 and occurrence of osteoporotic fractures in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Effects of short term administration of recombinant human growth hormone to elderly people

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Recombinant human growth hormone, but not insulin-like growth factor-I, enhances central fat loss in postmenopausal women undergoing a diet and exercise program

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Impaired growth hormone secretion in the adult population: relation to age and adiposity

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Effects of sex and age on the 24-hour profile of growth hormone secretion in man: importance of endogenous estradiol concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Age and relative adiposity are specific negative determinants of the frequency and amplitude of growth hormone (GH) secretory bursts and the half-life of endogenous GH in healthy men.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Nyctohemeral growth hormone profiles in young and aged men: correlation with somatomedin-C levels

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Abscence of sleep-related growth hormone peaks in aged normal subjects and in acromegaly

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Plasma growth hormone during sleep in young and aged men.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Changes in Cortisol and Growth Hormone Secretion During Nocturnal Sleep in the Course of Aging

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Glucocorticoid action and the clinical features of Cushing's syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Bone mineral density and bone turnover before and after surgical cure of Cushing's syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Reversibility of steroid-induced osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Body Composition in Cushing's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Cushing's syndrome in children and adolescents. Presentation, diagnosis, and therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Cushing's syndrome--killing disease: discriminatory value of signs and symptoms aiding early diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Body fat distribution measured with CT: correlations in healthy subjects, patients with anorexia nervosa, and patients with Cushing syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Changes in body composition and adipose tissue distribution after treatment of women with Cushing's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Cortisol secretion in relation to body fat distribution in obese premenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

The hypothalamic-pituitary-adrenal axis in obese women with different patterns of body fat distribution

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Stress-induced cortisol response and fat distribution in women

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Is hypothalamic-pituitary-adrenal hyperactivity important in the pathogenesis of excessive abdominal fat distribution?

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Stress update Adaptation of the hypothalamic-pituitary-adrenal axis to chronic stress

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

A glucocorticoid receptor gene marker is associated with abdominal obesity, leptin, and dysregulation of the hypothalamic-pituitary-adrenal axis

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Sexual dimorphism in 11 beta hydroxysteroid dehydrogenase activity and its relation to fat distribution and insulin sensitivity; a study in hypopituitary subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

'The fat lady sings', but what is she telling us?

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Understanding the role of glucocorticoids in obesity: tissue-specific alterations of corticosterone metabolism in obese Zucker rats

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Metabolism of adipose tissue in intraabdominal depots in severely obese men and women

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Blockade of the Glucocorticoid Receptor with RU 486: Effects In Vitro and In Vivo on Human Adipose Tissue Lipoprotein Lipase Activity

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Growth hormone status following treatment for Cushing's syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Responses of plasma adrenocorticotropin, cortisol, and dehydroepiandrosterone to ovine corticotropin-releasing hormone in healthy aging men.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

The sex difference in plasma cortisol concentration in man

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Assessment of hypothalamic-pituitary-adrenal function in the geriatric age group.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Hypothalamic-pituitary-adrenal function in the elderly.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Lack of tissue glucocorticoid reactivation in 11beta -hydroxysteroid dehydrogenase type 1 knockout mice ameliorates age-related learning impairments

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Basal cortisol levels and cognitive deficits in human aging.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Cortisol levels during human aging predict hippocampal atrophy and memory deficits.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Glucocorticoid hypersecretion and the age-impaired hippocampus: cause or effect?

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

The adrenocortical axis in the aged rat: impaired sensitivity to both fast and delayed feedback inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Human glucocorticoid feedback inhibition is reduced in older individuals: evening study

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Glucocorticoids and neuroendocrine function

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Steroids, stability and stress.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

On the Role of Brain Mineralocorticoid (Type I) and Glucocorticoid (Type II) Receptors in Neuroendocrine Regulation

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Cloning of human mineralocorticoid receptor complementary DNA: structural and functional kinship with the glucocorticoid receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Differences in Corticosterone and Dexamethasone Binding to Rat Brain and Pituitary1

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

The steroid and thyroid hormone receptor superfamily

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Two receptor systems for corticosterone in rat brain: microdistribution and differential occupation

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Binding characteristics of mineralocorticoid and glucocorticoid receptors in dog brain and pituitary

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Species-specificity of corticosteroid receptors in hamster and rat brains

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Hippocampal aging and adrenocorticoids: quantitative correlations

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Glucocorticoid endangerment of the hippocampus: tissue, steroid and receptor specificity.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Hypothalamo-pituitary-adrenocortical dysregulation in aging F344/Brown-Norway F1 hybrid rats.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Spontaneous and Glucocorticoid-Inhibited Adrenocorticotropic Hormone and Cortisol Secretion are Similar in Healthy Young and Old Men*

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Gender differences in age-related changes in HPA axis reactivity.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Elderly subjects show severe impairment of dehydroepiandrosterone sulphate and reduced sensitivity of cortisol and aldosterone response to the stimulatory effect of ACTH(1-24).

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Physiological Functions of Glucocorticoids in Stress and Their Relation to Pharmacological Actions*

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

The dexamethasone suppression test in normal control subjects: comparison of two assays and effect of age

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Cortisol secretion in relation to age in major depression

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Age and the dexamethasone suppression test in depression

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Influence of age on the cortisol response to dexamethasone.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Occurrence of high concentrations of postdexamethasone cortisol in elderly psychiatric inpatients

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Cortisol and Alzheimer's disease, II: Dexamethasone suppression, dementia severity, and affective symptoms.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Urinary free cortisol in psychotic depression

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Interperson variability but intraperson stability of baseline plasma cortisol concentrations, and its relation to feedback sensitivity of the hypothalamo-pituitary-adrenal axis to a low dose of dexamethasone in elderly individuals

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Aging is without effect on the pituitary-adrenal axis in men

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

The pituitary-adrenal glucocorticoid response is altered by gender and disease

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

A polymorphism in the regulatory region of the corticotropin-releasing hormone gene in relation to cortisol secretion, obesity, and gene-gene interaction

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Immunocytochemical and molecular analysis of the effects of glucocorticoid treatment on the hypothalamic-somatotropic axis in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Gene expression of hypothalamic somatostatin and growth hormone-releasing hormone in dexamethasone-treated rats

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Regulation of hypothalamic somatostatin, growth hormone-releasing hormone, and growth hormone receptor messenger ribonucleic acid by glucocorticoids

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Corticosterone modulates growth hormone-releasing factor and somatostatin in fetal rat hypothalamic cultures

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Cortisol stimulation of growth hormone production by monkey adenohypophysis in tissue culture.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Effects of synthetic human pancreatic (tumor) GH releasing factor and somatostatin, triiodothyronine and dexamethasone on GH secretion in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Control of growth hormone production by a clonal strain of rat pituitary cells. Stimulation by hydrocortisone

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Depending on the time of administration, dexamethasone potentiates or blocks growth hormone-releasing hormone-induced growth hormone release in man

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Night and day growth hormone levels during treatment with corticosteroids and corticotrophin

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Responses of plasma ACTH, GH, LH and 11-hydroxycorticosteroids to various stimuli in patients with Cushing's syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Inhibition by prednisone of growth hormone (GH) response to GH-releasing hormone in normal men.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Sleep EEG stages and plasma growth hormone concentration in states of endogenous and exogenous hypercortisolemia or ACTH elevation

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Human pancreatic growth hormone releasing hormone fails to stimulate human growth hormone both in Cushing's disease and in Cushing's syndrome due to adrenocortical adenoma

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Joint Growth Hormone and Cortisol Spontaneous Secretion Is More Asynchronous in Older Females Than in Their Male Counterparts

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Pathophysiology of the neuroregulation of growth hormone secretion in experimental animals and the human.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Growth hormone increases cortical and cancellous bone mass in young growing rats with glucocorticoid-induced osteopenia

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Growth hormone and lean tissue catabolism during long-term glucocorticoid treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Growth hormone prevents steroid-induced growth depression in health and uremia

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Muscle and adipose tissue morphology and metabolism in Cushing's syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Insulin-like growth factor 1 inhibits glucocorticoid-induced glutamine synthetase activity in cultured L6 rat skeletal muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Increased proteolysis. An effect of increases in plasma cortisol within the physiologic range

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Evidence that prednisone-induced myopathy is reversed by physical training

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Thigh muscle mass and function in patients treated with glucocorticoids

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Hormonal regulation of protein degradation in skeletal and cardiac muscle

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Branched chain amino acids activate messenger ribonucleic acid translation regulatory proteins in human skeletal muscle, and glucocorticoids blunt this action

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Human growth hormone prevents the protein catabolic side effects of prednisone in humans

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Modulation of cortisol metabolism by the growth hormone receptor antagonist pegvisomant in patients with acromegaly

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Minireview: 11beta-hydroxysteroid dehydrogenase type 1- a tissue-specific amplifier of glucocorticoid action

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

11Beta-hydroxysteroid-dehydrogenase isoforms: tissue distribution and implications for clinical medicine

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Cortisol metabolism and the role of 11beta-hydroxysteroid dehydrogenase

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Adrenal 11 beta-hydroxysteroid dehydrogenase

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Molecular basis for hypertension in the "type II variant" of apparent mineralocorticoid excess

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Immunohistochemical localization of type 1 11beta-hydroxysteroid dehydrogenase in human tissues

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

11Beta-hydroxysteroid dehydrogenase 1 in adipocytes: expression is differentiation-dependent and hormonally regulated

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

A transgenic model of visceral obesity and the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

The effect of growth hormone replacement therapy on cortisol-cortisone interconversion in hypopituitary adults: evidence for growth hormone modulation of extrarenal 11 beta-hydroxysteroid dehydrogenase activity

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Ghrelin: discovery of the natural endogenous ligand for the growth hormone secretagogue receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Ghrelin is a growth-hormone-releasing acylated peptide from stomach

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Ghrelin and des-acyl ghrelin: two major forms of rat ghrelin peptide in gastrointestinal tissue

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

A receptor in pituitary and hypothalamus that functions in growth hormone release

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Identification of a new G-protein-linked receptor for growth hormone secretagogues

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Ghrelin Strongly Stimulates Growth Hormone Release in Humans

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Growth hormone-releasing activity of hexarelin in humans. A dose-response study

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Twenty-four-hour growth hormone (GH)-releasing peptide (GHRP) infusion enhances pulsatile GH secretion and specifically attenuates the response to a subsequent GHRP bolus

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

On the in vitro and in vivo activity of a new synthetic hexapeptide that acts on the pituitary to specifically release growth hormone

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Growth hormone-releasing peptides

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

The growth hormone secretagogue hexarelin stimulates the hypothalamo-pituitary-adrenal axis via arginine vasopressin.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Activation of the hypothalamo-pituitary-adrenal axis by the growth hormone (GH) secretagogue, GH-releasing peptide-6, in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Growth hormone secretagogue receptor expression in human pituitary tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Presence of growth hormone secretagogue receptor messenger ribonucleic acid in human pituitary tumors and rat GH3 cells

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Expression of the Growth Hormone Secretagogue Receptor in Pituitary Adenomas and Other Neuroendocrine Tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Novel hexarelin analogs stimulate feeding in the rat through a mechanism not involving growth hormone release

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Glucocorticoid regulation of growth hormone (GH) secretagogue-induced growth responses and GH secretagogue receptor expression in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Hormonal regulation of the human ghrelin receptor gene transcription

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Genomic structure and transcriptional regulation of the human growth hormone secretagogue receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Ghrelin is an appetite-stimulatory signal from stomach with structural resemblance to motilin

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Ghrelin: an orexigenic and somatotrophic signal from the stomach

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

A role for ghrelin in the central regulation of feeding

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

The novel hypothalamic peptide ghrelin stimulates food intake and growth hormone secretion

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

Ghrelin, an endogenous growth hormone secretagogue, is a novel orexigenic peptide that antagonizes leptin action through the activation of hypothalamic neuropeptide Y/Y1 receptor pathway.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2802%2900022-9

7 January 2021

10.1016/S1096-6374(02)00022-9

Identifiers

DOI

1 reference

16 June 2017

1 reference